BioCardia ( NASDAQ: BCDA ) announced that, following approval by the company's stockholders and its Board of Directors, the company intends to effect a reverse stock split of its common stock at a ratio of 1 post-split share for every 15 pre-split shares. The reverse stock split will become effective at 12:01 a.m.
Eastern Daylight Time on Thursday, May 30, 2024. The company’s common stock will begin trading on a split-adjusted basis when the market opens on Thursday, May 30, 2024. Source: Press Release .
More on BioCardia BioCardia, Inc. (BCDA) Q1 2024 Earnings Call Transcript BioCardia, Inc. (BCDA) Q4 2023 Earnings Call Transcript BioCardia spikes after Medicare coverage for cell therapy trial Seeking Alpha’s Quant Rating on BioCardia Financial information for BioCardia.
